5 facts you need to know about Pro Medicus Limited today

Credit: Unsplash

Pro Medicus Limited (ASX: PME) has today reported a massive 83% surge in profit for the half year ending December 31.

While the share price has slipped around 3% in a soft market which has seen the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) drop 0.6%, over the past 12 months Pro Medicus’ share price has still recorded a gain of over 100%!

The interim financial results reported the following five facts:

  1. Revenue leapt 65% to $14.3 million
  2. Underlying profit from operations (which excludes the effects of currency gains and one-offs) surged 188.5% to $2.8 million
  3. An unfranked dividend of 1.5 cents per share has been declared. The stock will trade ex-dividend on March 10, with payment on March 25
  4. The company remains debt free and with cash reserves of $16.2 million
  5. Forward contracted revenue over the next five years now totals more than $60 million

What now

The drivers of the improved performance included the North American business where sales more than doubled thanks to Pro Medicus winning some significant contracts in the region such as the $11 million contract with Allegheny Health Network, a large health system in the Pittsburgh area.

The group’s European business also performed strongly thanks to a $3 million deal with a German government hospital network.

Pro Medicus’ Visage 7 product appears to be enjoying positive sales momentum and this has resulted in the market driving the share price significantly higher over the past year.

Word of caution

As I noted in this previous article, a number of ASX information technology companies have appealing products and business models but investors do need to consider the price they are paying compared with the value they are receiving in each instance.

It appears all is tracking to market expectations for Pro Medicus for now, however, as shareholders in 3P Learning Ltd (ASX: 3PL) are witnessing today – the stock is down over 20% – failing to deliver the lofty expectations of the market can lead to a dramatic decline in assessed value.

The technology that's going to REPLACE the Internet is already here...

Dollar for dollar, insiders are calling it one of the biggest new markets in the history of modern business... NOW is the time to get in on the hush-hush industry that could be poised for growth of over 4,463%+ by 2020... And the 1 ASX stock that stands to grow YOUR money right alongside it! Simply click here to learn its name.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.